[Current status of xylitol].
D000311:Adrenal Glands / Q000187:drug effects; D000309:Adrenal Insufficiency / Q000188:drug therapy; D000438:Alcohols / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D050260:Carbohydrate Metabolism; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D016883:Diabetic Ketoacidosis / Q000188:drug therapy; D004912:Erythrocytes / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007408:Intestinal Absorption; D050356:Lipid Metabolism; D008107:Liver Diseases / Q000188:drug therapy*; D010179:Pancreas / Q000187:drug effects*; D014993:Xylitol / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D014994:Xylose / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use
D000438:Alcohols; D007328:Insulin; D014994:Xylose; D014993:Xylitol